The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer

Int J Colorectal Dis. 1989 Dec;4(4):230-3. doi: 10.1007/BF01644987.

Abstract

Eighty-eight consecutive patients who underwent curative resection for colorectal cancer between 1983 and 1985 were studied prospectively to evaluate the roles of sequential CEA, TPA and CA 19-9 determinations and independent clinical examination in the early diagnosis of resectable recurrences. Twenty nine recurrences were detected between 8 and 38 months after primary surgery. CEA, TPA and CA 19-9 showed a sensitivity of 72%, 62% and 38%, and a specificity of 78%, 86% and 97%, respectively. Of eight recurrences in which CEA was not raised, five induced a rise in TPA and two a rise in CA 19-9. The rise in the serum concentration of one of the three markers was the first sign of relapse in 23 (79%) patients. Two second-look laparotomies based solely on a rise in serum markers were performed. In one case diffuse recurrent disease was found, and in the other a resectable solitary hepatic metastasis was found.

MeSH terms

  • Aged
  • Antigens, Tumor-Associated, Carbohydrate / blood*
  • Biomarkers, Tumor / blood*
  • Carcinoembryonic Antigen / blood*
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / mortality
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Metastasis
  • Peptides / blood*
  • Predictive Value of Tests
  • Reoperation
  • Sensitivity and Specificity
  • Tissue Polypeptide Antigen

Substances

  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Peptides
  • Tissue Polypeptide Antigen